Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Galectin Therapeutics Q3 EPS $(0.14), Same YoY

Galectin Therapeutics Q3 EPS $(0.14), Same YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.

Earnings

PTC: Q1 Earnings Insights

By Benzinga Insights

January 31, 5:05 PM

PTC (NASDAQ:PTC) reported its Q1 earnings results on Wednesday, January 31, 2024 at 04:01 PM. Here’s what investors…

PTC

Meta’s Bold Move: Paid, Ad-Free Versions For European Audience

By Bibhu Pattnaik

September 2, 2:07 PM

In a move that could reshape the social media landscape, Meta (NASDAQ: META), the powerhouse behind platforms such as Facebook, Instagram and WhatsApp, is mulling over the introduction

In Biden Vs. Trump Race, Elon Musk Only Stands To Lose, But One Spells More Trouble Than The Other, Say Experts: ‘Be Careful What You Wish For’

By Navdeep Yadav

June 18, 2:43 AM

Experts caution that whether Joe Biden or Donald Trump returns to the White House, Musk's businesses face significant challenges.

TSLA

Movers
News

Why Carnival (CCL) Shares Are Higher Tuesday

By Erica Kollmann

June 27, 10:54 AM

Carnival Corporation (NYSE: CCL) shares are trading higher on Tuesday as the stock rebounds after falling Monday on second-quarter earnings. Multiple analysts raised price targets on Tuesday. The Details:

CCL

Galectin Therapeutics Q3 EPS $(0.14), Same YoY

Related Posts

PTC: Q1 Earnings Insights

Meta’s Bold Move: Paid, Ad-Free Versions For European Audience

In Biden Vs. Trump Race, Elon Musk Only Stands To Lose, But One Spells More Trouble Than The Other, Say Experts: ‘Be Careful What You Wish For’

Why Carnival (CCL) Shares Are Higher Tuesday